Pfizer's Heading for a Patent Cliff

Pfizer's Heading for a Patent Cliff

Source: 
Motley Fool
snippet: 

  • Pfizer’s older blockbusters are set to lose exclusivity soon, meaning billions of dollars in lost revenue.
  • But the company’s near-to-market candidates and products gained through acquisitions could spur a whole new wave of growth.